Thiomersal dans les vaccins : Pas de panique ! = Thiomersal in vaccines : No panic !La Revue Prescrire. 1999, Vol 19, Num 199, issn 0247-7750, p. 670Article

Stability of influenza sub-unit vaccine Does a couple of days outside the refrigerator matter?COENEN, F; TOLBOOM, J. T. B. M; FRIJLINK, H. W et al.Vaccine. 2006, Vol 24, Num 4, pp 525-531, issn 0264-410X, 7 p.Article

Embryonic exposure to thimerosal, an organomercury compound, causes abnormal early development of serotonergic neuronsIDA-ETO, Michiru; OYABU, Akiko; OHKAWARA, Takeshi et al.Neuroscience letters. 2011, Vol 505, Num 2, pp 61-64, issn 0304-3940, 4 p.Article

TRANSPORT ATPASE - THE DIFFERENT MODES OF INHIBITION OF THE ENZYME BY VARIOUS MERCURY COMPOUNDSHENDERSON GR; WU HSIUNG HUNAG; ASKARI A et al.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 3; PP. 429-433; BIBL. 15 REF.Article

Lactic acid triggers, in vitro, thiomersal to degrade protein in the presence of PLGA microspheresNAMUR, Jocimara A. M; TAKATA, Célia S; MORO, Ana M et al.International journal of pharmaceutics. 2004, Vol 273, Num 1-2, pp 1-8, issn 0378-5173, 8 p.Article

Gender-selective toxicity of thimerosalBRANCH, Donald R.Experimental and toxicologic pathology (Print). 2009, Vol 61, Num 2, pp 133-136, issn 0940-2993, 4 p.Article

Determinants of influenza vaccine purchasing decision in the US: A conjoint analysisPEREIRA, Claudia C. A; MULLIGAN, Matthew; BRIDGES, John F. P et al.Vaccine. 2011, Vol 29, Num 7, pp 1443-1447, issn 0264-410X, 5 p.Article

Thimerosal Disappears but Autism Remains. CommentaryFOMBONNE, Eric; SCHECHTER, Robert; GRETHER, Judith K et al.Archives of general psychiatry. 2008, Vol 65, Num 1, issn 0003-990X, 15-24 [8 p.]Article

The effects of some formulation factors used in ophthalmic preparations on thiomersal activity against Pseudomonas aeruginosa and Staphylococcus aureusABUQADDOM, A. I; DARWISH, R. M; MUTI, H et al.Journal of applied microbiology (Print). 2003, Vol 95, Num 2, pp 250-255, issn 1364-5072, 6 p.Article

Early thimerosal exposure and neuropsychological outcomes at 7 to 10 yearsTHOMPSON, William W; PRICE, Cristofer; DUNN, John et al.The New England journal of medicine. 2007, Vol 357, Num 13, pp 1281-1292, issn 0028-4793, 12 p.Article

Sensitization to thimerosal in atopic childrenPATRIZI, A; RIZZOLI, L; VINCENZI, C et al.Contact dermatitis. 1999, Vol 40, Num 2, pp 94-97, issn 0105-1873Article

Vaccines without thiomersal : Why so necessary, why so long coming?VAN'T VEEN, Albert-Jan.Drugs (Basel). 2001, Vol 61, Num 5, pp 565-572, issn 0012-6667Article

In Vitro Activity of Thimerosal against Ocular Pathogenic FungiYAN XU; GUANGREN PANG; DONGQING ZHAO et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 1, pp 536-539, issn 0066-4804, 4 p.Article

A systematic study of the disposition and metabolism of mercury species in mice after exposure to low levels of thimerosal (ethylmercury)HORNOS CARNEIRO, Maria Fernanda; OLIVEIRA SOUZA, Juliana Maria; GROTTO, Denise et al.Environmental research (New York, N.Y. : Print). 2014, Vol 134, pp 218-227, issn 0013-9351, 10 p.Article

Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particlesHARMSEN, M. M; FIJTEN, H. P. D; WESTRA, D. F et al.Vaccine. 2011, Vol 29, Num 15, pp 2682-2690, issn 0264-410X, 9 p.Article

Prenatal and Postnatal Mercury Exposure, Breastfeeding and Neurodevelopment During the First 5 YearsMARQUES, Rejane C; DOREA, José G; BERNARDI, José V. E et al.Cognitive and behavioral neurology. 2009, Vol 22, Num 2, pp 134-141, issn 1543-3633, 8 p.Article

Kawasaki's Disease, Acrodynia, and MercuryMUTTER, J; YETER, D.Current medicinal chemistry. 2008, Vol 15, Num 28, pp 3000-3010, issn 0929-8673, 11 p.Article

Contact sensitivity to preservatives in TurkeyBOYVAT, Ayse; AKYOL, Aynur; GÜRGEY, Erbak et al.Contact dermatitis. 2005, Vol 52, Num 6, pp 329-332, issn 0105-1873, 4 p.Article

The evidence for the safety of thiomersal in newborn and infant vaccinesCLEMENTS, C. John.Vaccine. 2004, Vol 22, Num 15-16, pp 1854-1861, issn 0264-410X, 8 p.Article

Technologies that make administration of vaccines saferCLEMENTS, C. John; LARSEN, Gordon; JODAR, Luis et al.Vaccine. 2004, Vol 22, Num 15-16, pp 2054-2058, issn 0264-410X, 5 p.Conference Paper

Thiomersal in vaccines. Is removal warranted?JOHN CLEMENTS, C; BALL, Leslie K; BALL, Robert et al.Drug safety. 2001, Vol 24, Num 8, pp 567-574, issn 0114-5916Article

Route of decomposition of thiomersal (thimerosal)TAN, M; PARKIN, J. E.International journal of pharmaceutics. 2000, Vol 208, Num 1-2, pp 23-34, issn 0378-5173Article

Allergic contact dermatitis from thimerosal in an electrophoresis gelRAMSAY, H. M; TAN, B. B.Contact dermatitis. 1998, Vol 39, Num 4, issn 0105-1873, p. 205Article

Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of lifeMROZEK-BUDZYN, Dorota; MAJEWSKA, Renata; KIELTYKA, Agnieszka et al.Neurotoxicology and teratology. 2012, Vol 34, Num 6, pp 592-597, issn 0892-0362, 6 p.Article

Thimerosal Exposure in Early Life and Neuropsychological Outcomes 7―10 Years LaterBARILE, John P; KUPERMINC, Gabriel P; WEINTRAUB, Eric S et al.Journal of pediatric psychology. 2012, Vol 37, Num 1, pp 106-118, issn 0146-8693, 13 p.Article